Nucleos(t)ide analogue treatment in hepatitis B: to stop or not to stop?

INTRODUCTION: Monotherapy with a nucleos(t)ide analogue (NA), namely entecavir and tenofovir, represents the mainstay of hepatitis B virus (HBV) treatment, which achieves potent viral suppression and subsequently improved major outcomes, but it rarel…

Preview only. Read the full abstract at the source